US 11053213
Pharmaceutical compounds
granted A61PA61P21/00A61P25/16
Quick answer
US patent 11053213 (Pharmaceutical compounds) held by ALMAC DISCOVERY LIMITED expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ALMAC DISCOVERY LIMITED
- Grant date
- Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61P, A61P21/00, A61P25/16, A61P35/00